J J Treanor

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. ncbi request reprint Evaluation of live, cold-adapted influenza A and B virus vaccines in elderly and high-risk subjects
    J J Treanor
    University of Rochester, Infectious Diseases Unit, NY 14642, USA
    Vaccine 16:1756-60. 1998
  2. ncbi request reprint Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses
    J J Treanor
    Infectious Diseases Unit, Department of Medicine, University of Rochester School of Medicine, Box 689, 601 Elmwood Avenue, Rochester, NY 14642, USA
    Vaccine 18:899-906. 1999
  3. ncbi request reprint Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans
    J J Treanor
    Infectious Diseases Unit, University of Rochester, 601 Elmwood Avenue, Rochester, NY 14642, USA
    Vaccine 19:1732-7. 2001
  4. ncbi request reprint Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group
    J J Treanor
    Infectious Diseases Unit, University of Rochester, NY 14642, USA
    JAMA 283:1016-24. 2000

Detail Information

Publications4

  1. ncbi request reprint Evaluation of live, cold-adapted influenza A and B virus vaccines in elderly and high-risk subjects
    J J Treanor
    University of Rochester, Infectious Diseases Unit, NY 14642, USA
    Vaccine 16:1756-60. 1998
    ..Further studies of multivalent cold-adapted influenza vaccines used in combination with inactivated vaccine should be performed...
  2. ncbi request reprint Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses
    J J Treanor
    Infectious Diseases Unit, Department of Medicine, University of Rochester School of Medicine, Box 689, 601 Elmwood Avenue, Rochester, NY 14642, USA
    Vaccine 18:899-906. 1999
    ..These results are consistent with those of previous studies using monovalent preparations of cold-adapted influenza vaccine in this model, and indicate that CAIV-T will be an effective means to prevent influenza illness in adults...
  3. ncbi request reprint Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans
    J J Treanor
    Infectious Diseases Unit, University of Rochester, 601 Elmwood Avenue, Rochester, NY 14642, USA
    Vaccine 19:1732-7. 2001
    ..These results suggest that baculovirus-expressed H5 HA can induce functional antibody in individuals who have not had prior exposure to H5 viruses, but that further studies to improve the immunogenicity of the vaccine are needed...
  4. ncbi request reprint Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group
    J J Treanor
    Infectious Diseases Unit, University of Rochester, NY 14642, USA
    JAMA 283:1016-24. 2000
    ..Previous studies have shown oseltamivir, a neuraminidase inhibitor, to be effective in preventing influenza and treating experimental influenza...